Key result
Unexplained venous thromboembolism is associated with an increased incidence of newly diagnosed malignancy during the first 6 to 12 months after the thromboembolic event.
Why the study?
Is extensive diagnostic work-up for occult malignancies cost-effective in all patients presenting with unexplained venous thromboembolism?
Population
Patients with unexplained venous thromboembolism
Design
Review
Authors
Loading...
Supports selective occult cancer screening after unexplained VTE; leaves open whether extensive work-up is cost-effective.
Is extensive diagnostic work-up for occult malignancies cost-effective in all patients presenting with unexplained venous thromboembolism?
Unexplained venous thromboembolism can be the first manifestation of cancer, warranting consideration for occult malignancy screening, although its cost-effectiveness is not yet established.
Monréal et al. (1999) conducted a review in Unexplained venous thromboembolism. Unexplained venous thromboembolism was evaluated on Newly diagnosed malignancy. Unexplained venous thromboembolism is associated with an increased incidence of newly diagnosed malignancy during the first 6 to 12 months after the thromboembolic event.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: